ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2009

Aug 19, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2009-03-26

Reporting Person: McKenney Charles (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-26	Stock Option	$0.49	A	40000	Acquired	2019-03-26	Common Stock (40000)	Direct